Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Investors were disappointed with Physitrack PLC's (STO:PTRK) earnings, despite the strong profit numbers. We did some digging and found some worrying underlying problems.

See our latest analysis for Physitrack

The Impact Of Unusual Items On Profit

To properly understand Physitrack's profit results, we need to consider the €3.5m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. We can see that Physitrack's positive unusual items were quite significant relative to its profit in the year to September 2024. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Physitrack's Profit Performance

As we discussed above, we think the significant positive unusual item makes Physitrack's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Physitrack's underlying earnings power is lower than its statutory profit. But the happy news is that, while acknowledging we have to look beyond the statutory numbers, those numbers are still improving, with EPS growing at a very high rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you'd like to know more about Physitrack as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 3 warning signs for Physitrack you should know about.

This note has only looked at a single factor that sheds light on the nature of Physitrack's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.